Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Artelo Biosciences, Inc. (ARTL) had Non-Operating Income/Expense of $0.64M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
-- |
|
$-9.29M |
|
-- |
|
-- |
|
$9.93M |
|
$-9.93M |
|
|
Non-Operating Income/Expense |
$0.64M |
$-9.29M |
|
$-9.93M |
|
$-9.29M |
|
$-9.29M |
|
$-9.29M |
|
$-9.93M |
|
$-9.93M |
|
$-9.93M |
|
2.96M |
|
2.96M |
|
$-3.14 |
|
$-3.14 |
|
| Balance Sheet Financials | |
$10.98M |
|
-- |
|
$2.06M |
|
$13.04M |
|
$1.29M |
|
-- |
|
-- |
|
$1.29M |
|
$11.75M |
|
$9.71M |
|
$11.75M |
|
3.19M |
|
| Cash Flow Statement Financials | |
$-8.21M |
|
$3.51M |
|
$0.57M |
|
$6.89M |
|
$2.81M |
|
$-4.07M |
|
$1.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-79.04% |
|
-95.63% |
|
-71.22% |
|
-79.04% |
|
$3.69 |
|
$-2.77 |
|
$-2.77 |
|